Integris Participates in Trial for Breast Cancer Prevention

By Gregory Potts Journal Record Reporter | THE JOURNAL RECORD, April 7, 1998 | Go to article overview

Integris Participates in Trial for Breast Cancer Prevention


Gregory Potts Journal Record Reporter, THE JOURNAL RECORD


Integris Baptist Medical Center has participated in what health officials call a historic advance for breast cancer prevention.

Dr. Richard Klausner, the director of the National Cancer Institute, presented the results of the Breast Cancer Prevention Trial, which show a drug called tamoxifen is capable of reducing the risk of breast cancer 40 percent to 50 percent among women at high risk.

"This is the first imperfect, but very encouraging, step toward finding drugs" that prevent a number of different kinds of cancer, he said. Due to the highly significant results, investigators decided to release the initial study results about 14 months earlier than expected and to mail letters announcing the breakthrough to the 13,388 women in the United States and Canada who participated in the study. Sixty women were involved at Integris Baptist, the only Oklahoma City hospital to participate in the study. One of the study's participants, 44-year-old Fay Duvall of Oklahoma City, was considered at high risk for breast cancer after her identical twin sister developed it in 1991 and died in 1994. Duvall, who took part in the study from 1992-97, just received the letter about the research Saturday - finding out the pills she had taken were tamoxifen instead of a placebo. "I probably smiled all weekend," she said. Karl Boatman, a general surgeon who directed the local portion of the study, called it a major breakthrough. "This was probably the most significant revelation that's come out of any of our clinical trials to prevent cancer," said Boatman. "We are now in a position to give women an option. We can now intervene prior to the detection of breast cancer and really reduce a woman's chance of developing the disease," said Leslie Ford, the National Cancer Institute official overseeing the trial. Government officials acknowledged that the protection came with an increased risk of another type of cancer and of blood clots. But the research clearly showed, Klausner said, that the benefits for women at high risk in preventing breast cancer outweighed the risk of side effects from taking the drug. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Integris Participates in Trial for Breast Cancer Prevention
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.